Overall survival rate | Disease-free survival rates | ||
The baseline characteristics before RFA | P value | The baseline characteristics before RFA | P value |
Age, younger (<70): older (≥70) | NS (0.748) | Age, younger (<70): older (≥70) | NS (0.233) |
Gender, male: female | NS (0.843) | Gender, male: female | NS (0.650) |
Child-Pugh, Class A: Class B | 0.007 | Child-Pugh, Class A: Class B | NS (0.163) |
Serum AFP level, <100 ng/mL: ≥100 ng/mL | NS (0.551) | Serum AFP level, <100 ng/mL: ≥100 ng/mL | NS (0.390) |
Serum PIVKA-2 level, <100 ng/mL: ≥100 ng/mL | NS (0.092) | Serum PIVKA-2 level, <100 ng/mL: ≥100 ng/mL | NS (0.088) |
The clinic-pathologic characteristics related to RFA |
| The clinic-pathologic characteristics related to RFA |
|
Tumor size, <20 mm: ≥20 mm | NS (0.962) | Tumor size, <20 mm: ≥20 mm | NS (0.640) |
Ablated margin, <5 mm: ≥5 mm | NS (0.087) | Ablated margin, <5 mm: ≥5 mm | NS (0.616) |
RFA alone: combined RFA and TACE | NS (0.097) | RFA alone: Combined RFA and TACE | NS (0.950) |
Local recurrence | NS (0.92) | Local recurrence | NS (0.071) |
The characteristics before hepatectomy |
| The characteristics before hepatectomy |
|
Child-Pugh, Class A: Class B | NS (0.286) | Child-Pugh, Class A: Class B | 0.004 |
Serum AFP level, <100 ng/mL: ≥100 ng/mL | NS (0.704) | Serum AFP level, <100 ng/mL: ≥100 ng/mL | NS (0.348) |
Serum PIVKA-2 level, <100 ng/mL: ≥100 ng/mL | NS (0.775) | Serum PIVKA-2 level, <100 ng/mL: ≥100 ng/mL | NS (0.235) |
Resected tumor size, <5 cm: ≥5 cm | NS (0.950) | Resected tumor size, <5 cm: ≥5 cm | NS (0.879) |
The characteristics after hepatectomy |
| The characteristics after hepatectomy |
|
Microvascular invasion, positive: negative | NS (0.097) | Microvascular invasion, positive: negative | NS (0.521) |
Differentiation, poorly: moderate/well | NS (0.852) | Differentiation, poorly: moderate/well | NS (0.743) |
Recurrence interval, <1 year: ≥1 year | NS (0.468) | Recurrence interval, <1 year: ≥1 year | NS (0.227) |